TrialAmerican journal of hypertension2021

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study.

Kazuomi Kario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.